Hypogonadism is when the sex glands (gonads) produce little or no sex hormones. Low sex hormone levels (testosterone and ...

Male hypogonadism is a deficiency in the sex hormone testosterone in adult males and male children. Also known as ...

The FDA has recommended several labeling changes to all approved testosterone replacement therapy products based on the ...

Pregnyl Market Report 2025 The Business Research Company's Pregnyl Market Report 2025– Market Size, Trends, And Global Forecast 2025-2034</ ...

A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...

The FDA has announced new labeling changes for all testosterone products following a review of clinical trial data, including a TRAVERSE study and postmarket ambulatory blood pressure studies.

Normosmic idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome are rare congenital forms of secondary hypogonadism characterized by delayed or absent sexual development.

The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.

Elderly. Nursing mothers: not recommended. Testosterone replacement therapy in adult males with congenital or acquired primary hypogonadism or hypogonadotropic hypogonadism. To stimulate puberty ...

Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...

Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke University School of Medicine to explore the ...